# Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

> **NCT02047162** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 400 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** Bismuth subsalicylate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02047162
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047162, "Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02047162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*